Published in Lung on October 04, 2008
Prognostic significance of grading in lung adenocarcinoma. Cancer (2010) 1.39
Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis. PLoS One (2014) 0.91
Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis. PLoS One (2012) 0.83
Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer. Cancer Med (2017) 0.75
Cancer. p53, guardian of the genome. Nature (1992) 16.36
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med (2004) 6.36
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J (2001) 3.04
Survival in early-stage non-small cell lung cancer. Ann Thorac Surg (1995) 2.01
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res (2000) 1.69
Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res (2000) 1.55
Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res (1992) 1.54
Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg (1984) 1.41
Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg (1990) 1.40
Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers. J Clin Oncol (2004) 1.25
E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann Thorac Surg (2001) 1.24
Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol (1987) 1.22
Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol (1995) 1.11
Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. Chest (2003) 1.11
A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg (1999) 1.10
Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg (1996) 1.08
Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer (1988) 1.07
Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less. J Thorac Oncol (2007) 1.07
The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection. J Thorac Cardiovasc Surg (1994) 1.02
Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg (1998) 1.00
A biological staging model for operable non-small cell lung cancer. Thorax (2001) 0.95
Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J Pathol (1996) 0.84
Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer. J Thorac Cardiovasc Surg (1993) 0.82
Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. Cancer (1995) 0.76
Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. J Thorac Oncol (2011) 2.89
Single-incision thoracoscopic surgery for primary spontaneous pneumothorax using the SILS port compared with conventional three-port surgery. Surg Endosc (2012) 2.54
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study. J Thorac Oncol (2014) 2.04
CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification. J Thorac Oncol (2010) 1.79
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma. Lung Cancer (2011) 1.66
Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg (2013) 1.60
How early can we repair pectus excavatum: the earlier the better? Eur J Cardiothorac Surg (2012) 1.57
Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. Cancer (2011) 1.49
New TNM staging system for esophageal cancer: what chest radiologists need to know. Radiographics (2014) 1.49
High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer. J Thorac Oncol (2010) 1.45
Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann Thorac Surg (2013) 1.44
High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features. J Thorac Oncol (2012) 1.44
Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression. J Thorac Oncol (2011) 1.43
Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET. J Surg Oncol (2006) 1.42
Endoscopic cryotherapy of lung and bronchial tumors: a systematic review. Korean J Intern Med (2011) 1.36
Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer. Lung Cancer (2006) 1.25
Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res Ther (2010) 1.24
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer (2011) 1.22
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet (2007) 1.20
The effect of postoperative change in bronchial angle on postoperative pulmonary function after upper lobectomy in lung cancer patients. Interact Cardiovasc Thorac Surg (2013) 1.17
Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma. Cancer Cell (2013) 1.17
Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. J Thorac Oncol (2009) 1.16
Otologic Manifestation in IgG4-Related Systemic Disease. Clin Exp Otorhinolaryngol (2011) 1.12
Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol (2008) 1.11
Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg (2006) 1.11
Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. J Thorac Oncol (2011) 1.10
Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am J Pathol (2005) 1.08
Alteration of the E-Cadherin/β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma. Korean J Pathol (2013) 1.07
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Eur J Radiol (2007) 1.04
Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer (2006) 1.02
The long-term course of ground-glass opacities detected on thin-section computed tomography. Respir Med (2013) 1.02
The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection. Lung Cancer (2009) 0.99
Angioleiomyoma in soft tissue of extremities: MRI findings. AJR Am J Roentgenol (2009) 0.99
Results of surgical treatment for pulmonary aspergilloma. Eur J Cardiothorac Surg (2002) 0.99
Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. J Clin Oncol (2009) 0.99
Giant cell tumor of soft tissue: a case with atypical US and MRI findings. Korean J Radiol (2008) 0.97
Clinical application of single incision thoracoscopic surgery: early experience of 264 cases. J Cardiothorac Surg (2014) 0.97
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake. Eur J Cancer (2008) 0.96
FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer. Virchows Arch (2014) 0.96
Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. Cancer Lett (2011) 0.94
High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas. Cancer Cytopathol (2012) 0.94
Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung. Lung Cancer (2008) 0.93
Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Clin Cancer Res (2009) 0.93
The accuracy of frozen section diagnosis of pulmonary nodules: evaluation of inflation method during intraoperative pathology consultation with cryosection. J Thorac Oncol (2010) 0.93
Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung. J Thorac Oncol (2010) 0.92
Additional mechanical pleurodesis after thoracoscopic wedge resection and covering procedure for primary spontaneous pneumothorax. Surg Endosc (2008) 0.92
Primary esophageal repair in Boerhaave's syndrome. Dis Esophagus (2008) 0.92
Prognostic factors of pulmonary metastasis from colorectal carcinoma. Interact Cardiovasc Thorac Surg (2013) 0.91
Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer. Eur J Cardiothorac Surg (2013) 0.91
The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma. Eur J Cardiothorac Surg (2009) 0.91
Long-term survival after pulmonary metastatectomy of hepatocellular carcinoma; treatment outcome or natural history? Hepatogastroenterology (2004) 0.91
Surgical resection of nodular ground-glass opacities without percutaneous needle aspiration or biopsy. BMC Cancer (2014) 0.91
Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocr J (2008) 0.90
Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. Anticancer Res (2005) 0.89
Neuroendocrine differentiation in acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitor. Tuberc Respir Dis (Seoul) (2013) 0.89
ROS1 gene rearrangement and copy number gain in non-small cell lung cancer. Virchows Arch (2014) 0.89
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol (2015) 0.88
Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases. Histopathology (2012) 0.88
Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer. Ann Surg Oncol (2010) 0.88
Aberrant methylation of ADAMTS1 in non-small cell lung cancer. Cancer Genet Cytogenet (2008) 0.87
Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer. Cancer Sci (2010) 0.87
Detection of anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer and related issues in ALK inhibitor therapy: a literature review. Mol Diagn Ther (2012) 0.86
A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer. J Thorac Oncol (2012) 0.86
MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas. Ann Surg Oncol (2013) 0.85
Microscopy coil for preoperative MRI of small soft-tissue masses of the hand and foot: comparison with conventional surface coil. AJR Am J Roentgenol (2008) 0.85
A functional variant at 19q13.3, rs967591G>A, is associated with shorter survival of early-stage lung cancer. Clin Cancer Res (2013) 0.85
Surgical resection of highly suspicious pulmonary nodules without a tissue diagnosis. Jpn J Clin Oncol (2011) 0.84
Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival. Otolaryngol Head Neck Surg (2008) 0.84
ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement. Virchows Arch (2013) 0.84
Does eosinophilic inflammation affect the outcome of endoscopic sinus surgery in chronic rhinosinusitis in Koreans? Am J Rhinol Allergy (2013) 0.83
Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World J Surg Oncol (2014) 0.83
Clinicopathological correlations of mTOR and pAkt expression in non-small cell lung cancer. Virchows Arch (2012) 0.83